These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3839181)

  • 41. The medical management of breast cancer.
    Costanza ME
    Clin Obstet Gynecol; 1982 Jun; 25(2):433-41. PubMed ID: 7105517
    [No Abstract]   [Full Text] [Related]  

  • 42. New attitudes in cancer treatment: breast cancer and adjuvant therapy.
    Cooperman EM
    Can Med Assoc J; 1976 Jul; 115(2):100, 102. PubMed ID: 1277065
    [No Abstract]   [Full Text] [Related]  

  • 43. Adjuvant hormono-chemotherapy in operable breast cancer.
    Wilson R; Hanham IW; Mair G; Drake SR; Derry CD; McKenzie C; Stoll BA; Boesen E; Skeggs DB; Senanayake F
    Lancet; 1978 May; 1(8073):1101. PubMed ID: 77399
    [No Abstract]   [Full Text] [Related]  

  • 44. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1992 Jan; 339(8785):71-85. PubMed ID: 1345869
    [No Abstract]   [Full Text] [Related]  

  • 45. Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies.
    Arriagada R; Rutqvist LE
    Lancet; 1991 Aug; 338(8766):535-8. PubMed ID: 1678800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of action of adjuvant chemotherapy in early breast cancer.
    Valagussa P; Bonadonna G
    Lancet; 1986 Nov; 2(8514):1035-6. PubMed ID: 2877194
    [No Abstract]   [Full Text] [Related]  

  • 47. Financial considerations in the use of adjuvant chemotherapy.
    Irvin RJ; Kuhn JG
    Cancer Treat Res; 1992; 60():207-22. PubMed ID: 1355987
    [No Abstract]   [Full Text] [Related]  

  • 48. Conservation therapy of breast cancer.
    Stewart HJ; Prescott RJ; Forrest PA
    Lancet; 1989 Jul; 2(8655):168-9. PubMed ID: 2567945
    [No Abstract]   [Full Text] [Related]  

  • 49. Treating the relapsed patient.
    Chlebowski RT
    Cancer Treat Res; 1992; 60():239-53. PubMed ID: 1355989
    [No Abstract]   [Full Text] [Related]  

  • 50. Adjuvant chemotherapy in early breast cancer.
    Raemaekers JM; Beex LV; Smals AG; Benraad TJ; Kloppenborg PW
    Lancet; 1986 Oct; 2(8511):861. PubMed ID: 2876301
    [No Abstract]   [Full Text] [Related]  

  • 51. Chemotherapy and tamoxifen for breast cancer.
    N Engl J Med; 1981 Oct; 305(17):1014-5. PubMed ID: 7278914
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of stage I breast cancer: the NSABP experience.
    Redmond C; Fisher CK; Costantino B; Wickerham J; Wolmark DL; Fisher N
    Horm Res; 1989; 32 Suppl 1():175-80. PubMed ID: 2613203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant chemotherapy for breast cancer.
    Buzdar AU; Hortobagyi GN
    JAMA; 1986 May; 255(17):2296. PubMed ID: 3959318
    [No Abstract]   [Full Text] [Related]  

  • 54. New evidence may expand indications for chemotherapy in breast cancer.
    Merz B
    JAMA; 1989 Sep; 262(9):1153. PubMed ID: 2761048
    [No Abstract]   [Full Text] [Related]  

  • 55. Review of mortality results in randomised trials in early breast cancer.
    Lancet; 1984 Nov; 2(8413):1205. PubMed ID: 6150246
    [No Abstract]   [Full Text] [Related]  

  • 56. Breast cancer 1985. What have we learned?
    Urban JA
    Cancer; 1986 Feb; 57(3):636-43. PubMed ID: 3510705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening and breast cancer.
    Smith DW
    N Engl J Med; 2006 Feb; 354(7):767-9; author reply 767-9. PubMed ID: 16482677
    [No Abstract]   [Full Text] [Related]  

  • 58. Specialist surgeons and survival in breast cancer. Large differences in survival are not explained.
    Baum M
    BMJ; 1996 May; 312(7039):1155. PubMed ID: 8620139
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical response to chemotherapy and hormone therapy as first treatment after therapeutic ovariectomy in advanced breast cancer patients.
    Preda F; Oriana S; Perozziello F; Botte G; Lo Russo V
    Tumori; 1982 Apr; 68(2):161-5. PubMed ID: 6214880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between age and the effect of adjuvant therapies in women with primary breast cancer.
    Howell A
    Horm Res; 1989; 32 Suppl 1():231-7. PubMed ID: 2613208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.